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Abstract.  Amyloid #-protein (AB), the principal con- 
stituent of senile plaques seen in Alzheimer's disease 
(AD),  is derived by proteolysis from the/~-amyloid 
precursor protein (/~PP).  The mechanism of A/3 
production in neurons,  which are hypothesized to be a 
rich source of A/3 in brain,  remains to be defined.  In 
this study, we describe a detailed localization of cell 
surface/3PP and its subsequent trafficking in primary 
cultured neurons.  Full-length cell surface/~PP was 
present primarily on perikarya and axons, the latter 
with a characteristic discontinuous pattern.  At growth 
cones, cell surface ~PP was inconsistently detected. 
By visualizing the distribution of #PP monoclonal an- 
tibodies added to intact cultures,/~PP was shown to 
be internalized  from distal axons or terminals and 
retrogradely transported back to perikarya in or- 
ganelles which colocalized with fluid-phase endocytic 
markers.  Retrograde transport of ~PP was shown in 
both hippocampal and peripheral  sympathetic neurons, 
the latter using a compartment culture system that iso- 
lated cell bodies from distal axons and terminals.  In 
addition,  we demonstrated that/3PP from distal axons 
was transcytotically transported to the surface of 
perikarya from distal axons in sympathetic neurons. 
Indirect evidence of this transcytotic pathway was ob- 
tained in hippocampal neurons using antisense oligo- 
nucleotide to the kinesin heavy chain to inhibit antero- 
grade/~PP transport.  Taken together,  these results 
demonstrate novel aspects of/3PP trafficking in neu- 
rons, including retrograde axonal transport and trans- 
cytosis. Moreover, the axonal predominance of cell 
surface/3PP is unexpected in view of the recent report 
of polarized sorting of/~PP to the basolateral domain 
of MDCK cells. 
ZHEIMER'S disease  (AD) * is  a  progressive,  neuro- 
degenerative  disorder  characterized  by the  extra- 
cellular deposition of amyloid protein in the brain 
parenchyma and in the walls of meningeal and cortical blood 
vessels (38).  These amyloid deposits are composed prin- 
cipally of the 39--43-amino  acid residue amyloid/~-protein 
(A3) (13). A/~ is derived from proteolytic cleavages of the 
3-amyloid precursor protein (3PP) (24),  a ubiquitously ex- 
pressed membrane-spanning  glycoprotein (46). Several 3PP 
isoforms are produced by alternative  splicing although  one 
isoform, designated 3PP695, is predominantly  expressed by 
neurons (42).  Cleavage of ~PP by an endoproteinase  desig- 
nated "c~-secretase" results in the secretion of soluble 3-amy- 
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loid precursor protein (flPPs),  a •100-kD  soluble NH2-ter- 
minal  fragment  of ~PP (46),  and membrane retention  of a 
10-kD  COOH-terminal  fragment  (39).  The  o~-secretase 
cleavage occurs within the A{3 region and therefore precludes 
formation of an intact Aft peptide (10, 41). Although present 
in all cell types studied to date, the oc-secretase pathway may 
be used to only a limited  extent in neurons (16, 21). 
In addition to the secretory pathway, flPP is also processed 
and degraded within an endosomal/lysosomal pathway. Full- 
length flPP can be internalized  from the cell surface and tar- 
geted to endosomes and lysosomes, where COOH-terminal 
fragments containing  the entire A~ sequence have been de- 
tected (14, 17). Similar  fragments  have also been identified 
in  human  brain  and  vasculature  (11, 45).  Whether  these 
COOH-terminal fragments are the precursors to A/~ has not 
been determined (11, 14). 
Recently, A# has been shown to be a product of normal 
cellular metabolism (I1, 19, 40), in that A/~ and a variety of 
closely related low molecular weight peptides (19) are con- 
stitutively  produced and released into the medium of cul- 
tured cells. The pathway resulting in A/~ production and re- 
lease has not been defined.  One recent study suggested that 
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in the constitutive production and release of AB in cultured 
CHO cells (28).  In these cells, full-length BPP is recycled 
after internalization, a step which may contribute to AB re- 
lease. In contrast to normeuronal cells, intracellular AB is 
readily detected in cultured neuronal cells and appears be- 
fore its release in medium (47).  How the mechanism of A/3 
production is different between neuronal and nonneuronal 
cells is unknown. 
In MDCK cells, a model system for polarized epithelial 
ceils, sorting and secretion of/~PPs are highly polarized (18). 
In these cells, 90% of/3PPs, AB, and 3 kD COOH-terminal 
peptide of AB (p3) are released into the basolateral compart- 
ment (18). This polarized secretion of BPP products is as- 
sociated with a 90% preferential localization of full-length 
BPP on the basolateral membrane surface. Because neurons 
are highly polarized cells, an analogy has been suggested be- 
tween the apical surface of MDCK cells and the axons of cul- 
tured hippocampal neurons (8). However, the assessment of 
membrane distribution in many of the studies was made by 
analyzing viral glycoproteins after infection (23).  Thus, the 
analysis of BPP provides an opportunity whereby the mem- 
brane distribution of an endogenous protein can be deter- 
mined in neurons. 
Localization of BPP in cultured rat hippocampal neurons 
and PC12 cells has recently been reported (5, 12). However, 
these studies described only the intracellular distribution of 
BPP. In addition, because only COOH-terminal antibodies 
were used, whether/~PP was present as a full-length or trun- 
cated molecule was not determined. Therefore, the traffick- 
ing of cell surface/3PP in neurons, an issue that may be cen- 
tral to cerebral AB production, has not been addressed, In 
this report, we describe the localization and trafficking path- 
ways  of cell  surface full-length /~PP in cultured rat hip- 
pocampal  and  sympathetic neurons.  In  addition,  using  a 
compartment culture system, we show that/~PP is internal- 
ized and retrogradely transported to the perikaryon from dis- 
tal  axonal  membrane  sites.  Finally, we  present  evidence 
showing the transcytosis of cell surface/3PP from axonal to 
somatic compartments in cultured neurons. 
Materials and Methods 
Cultures 
Rat Hippocampal Neurons. Hippocampal cultures were prepared from em- 
bryonic day 18 rats as previously described (2). In brief, cells from the dis- 
sected hippocampi were dissociated by trypsin (0.25% for 15 min at 37°C) 
followed by trituration with fire-polished Pasteur pipettes. The cells were 
plated at a density of 100,000  celis/60-mm culture dish on glass coverslips 
coated with poly-L-lysine (1 mg/ml) in MEM with 10% horse serum. After 
2-4 h, the medium was changed to 1 ml of MEM with N2 supplements, 
ovalbumin (0.1%),  and pyruvate (0.01 mg/ml) that had been conditioned in 
cultures of astroglial cells for 24 h. Coverslips plated with neurons were 
cocultured with astroglia. 
Compartment Culture. Dissociated sympathetic neurons from superior 
cervical ganglia of newborn rats were cultured in the center chamber of a 
three-compartment culture  system,  as  described  (4).  Briefly,  collagen- 
coated glass coverslips were scored with  18 parallel scratches to remove 
dried collagen. In this way, neurites advanced along the collagen channels 
bounded by the scratches. A Teflon divider similar to the original model 
(Tyler Research Instruments, Edmonton, Alberta) was seated on the cover- 
slips to create three compartments that were isolated from each other by 
silicone grease and oriented so that the scratches connected all three com- 
partments. The divider was placed on prewetted coverslips to prevent the 
silicone grease from adhering to the collagen. The resultant system was 
such that there was no diffusion of medium between compartments but 
penetrable to neurites advancing along the collagen channels beneath the 
silicone grease dam. Dissociated neurons were plated into the center com- 
partment at "°2 ganglia per dish. Neurons were cultured in serum free me- 
dia (20) and treated with 10/zM cytosine arabinoside at the time of plating 
to  eliminate nonneuronal cells.  In control experiments using iodinated 
monoclonal BPP antibody and [3H]Inulin,  less than 1% of the radiolabel 
diffused into the adjacent chamber after 6 h. 
Antibodies 
The monoclonai antibodies 5A3 and 167 (28) and goat polyclonal antibody 
207 (gift from Dr. B. Greenberg) (40) made against BPPs from transfeeted 
CHO or baculovirus-infected cells, respectively, were used in the studies. 
5A3 and 167 recognize nonoverlapping epitopes in the mid-region of/3PP 
and these two monocional antibodies were used together to obtain higher 
signal (28). Monoa,  alent Fab fragments of 5A3 and 167 were obtained by 
papain digestion and purified by protein A-Sepharose chromatography to 
remove Fc fragments and undigested IgGs. The monoclonal antibody 13G8 
(gift from Dr.  D.  Schenk) and polyclonal antibody C7  (33)  were raised 
against the carboxy terminus of BPP.  At the immunocytochemical level, 
these anti-/3PP antibodies, except for L-S/, did not recognize amyloid precur- 
sor like protein 2 (APLP2) expressed in transfected CHO cells (data not 
shown)(43).  Polyclonal antibodies 1963  (19)  and t~l  (gift from Dr.  Y. 
Ihara) were raised against 21-37 and 17-28 of AB sequence, respectively. 
Additional monoclonal antibodies included transferrin receptor (gift from 
Dr. I. Trowbridge), GAP-43,  synaptophysin (Boehringer Mannheim, Indi- 
anapolis,  IN),  MAP2 (Sigma Chem. Co.,  St.  Louis, MO), and kinesin 
heavy chain (Sigma), and polyclonal antibodies to B-tubulin (Sigma) and 
neuronal cell adhesion molecule (NCAM) (Chemicon, Temecula, CA). 
lmmunocytochemistry 
Cultured cells were fixed for 20 min with warm 4% formaldehyde in PBS 
containing 0.12 M sucrose. As necessary, cultures were treated with 0.3% 
Triton X-IO0 for 5 min at room temperature after fixation to permeabilize 
the  cell  membranes.  Without  detergent  permeabilization,  intracellular 
structures, such as tubulin, were not immunoreactive, demonstrating that 
only surface ~PP was visualized in untreated cells. After blocking in 10% 
BSA for 1 h at 370C, the fixed cultures were exposed to primary antibodies 
overnight at 4°C. After several PBS washes, the cells were incubated for 
1 h with rhodamine or FITC-conjugated secondary antibodies (/ackson Im- 
munoresearch Labs, West Grove, PA). 
In some experiments, double-labeling immunocytochemistry  was carried 
out with two monoclonal antibodies. In this case, the cells were first labeled 
with one monoclonai antibody, washed extensively, and incubated with an 
excess of Fab fragments of goat anti-mouse IgG (1:10) after manufacturer's 
instructions (Jackson Immunoresearch) so that all the primary antibodies 
(usually anti-BPP monoclonal antibodies) were sterically covered by goat 
Fab  fragments. Subsequently, the ceils were incubated with the second 
monoclonal antibody, followed by anti-goat and anti-mouse secondary anti- 
bodies to visualize the two different primary antibodies. Two control experi- 
ments confirmed the effectiveness of this approach. First, a control FITC- 
conjugated anti-mouse antibody was not immunoreactive in the presence 
of  excess Fab fragments of  goat anti-mouse antibody, the latter used to steri- 
cally mask the primary mouse monoclonal antibody. Second, the staining 
pattern of the double-labeled cultures is identical to immunostaining with 
each of the respective monoclonai antibodies alone. 
Internalization Study in Rat Hippocampal Neurons 
3- and 10-d-old rat hippocampal cultures were incubated with/~PP mono- 
clonal antibodies for 30 rain at 370C  together with ovalbumin or dextran 
conjugated to Texas  red (1  mg/ml) (Molecular Probes, Eugene, OR).  In 
some experiments, cultures were incubated with whole IgG or monovalent 
Fab fragments of IffPP antibodies for 1 h at 4°C, washed extensively, and 
then incubated at 37"C to exclude fluid phase internalization. After fixation, 
cells were permeabilized and incubated with FITC-conjugated secondary 
antibody to visualize the BPP monoclonal antibodies. Control studies in- 
cluded the addition of  nonimmune mouse IgG or Fab fragments added under 
identical incubation conditions and at the same concentration as ~PP anti- 
bodies. 
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Culture System 
After the sympathetic neurons have extended their neurites into the lateral 
chambers  (usually 4-6 d after plating),  monoclonal antibodies (5A3flG7) 
were added only to lateral compartments and incubated for 1 h at 37"C. Af- 
ter fixation with or without permeabilization,  the chambers were removed 
and cells were then incubated with FITC-conjugated secondary antibodies 
for visualization of primary antibodies. Control studies included the addi- 
tion  of either nonimmunc  mouse  IgG at identical  concentrations  in the 
lateral  chamber or ~PP antibodies in the central chamber. 
Antisense Oligonucleotides 
Kinesin heavy chain was inhibited by the addition of antisense oligonncleo- 
tides as described  (12). The 16-mer antisense phosphorothioate  modified 
oligonucleotide used in the study consisted of the sequence GGTCCGCCA- 
TCTTTCT, complementary  to bases  -6 to +10 of the rat kinesin cDNA 
sequence (12). A 16-mer sense oligonucleotide corresponding to the bases 
at -6 to +10 was used as control. Three days after plating of hippocampal 
neurons, either oligonucleotide was added in serum free medium at 50/tM, 
followed by 25 tiM 12 h later. After 36 h, the ceils were fixed and cell sur- 
face BPP detected with the monnclonal antibodies 5A3 and IG7 as described 
above. In addition,  uptake of Texas red-conjngated  human transferrin (20 
t~g/rni) (Molecular Probes) was determined in cultures treated with oligonu- 
cleotides.  Finally, washout experiments were performed  in some cultures 
for 48 h after withdrawal of oligonucleotides. 
Cell Surface Biotinylation 
Surface biotinylation was carried  out on 1  x  106 (5-d-old) hippocampal 
neurons with hydroxysulfosuccinimide-biotin  (Pierce, Rockford, IL). The re- 
agent was dissolved in PBS (pH 8) at 1 mg/ml and added to the cultures 
at 4"C. After thorough washing with PBS supplemented with 50 mM gly- 
cine, the cells were iysed with 19[ NP-40. Immunoprecipitution was carried 
out with C7 polyclonal antibody recognizing the COOH terminus of BPP. 
The immunopreeipitated biotinylated/3PP was fractionated on SDS-PAGE, 
transferred to nitrocellulose, incubated with an antibiotin menoclonal anti- 
body (Jackson lmmunoReseaeh),  and then detected with nSI-labeled goat 
anti-mouse antibody. After the autoradiogram was exposed and developed, 
the blot was incubated with C7 antibody followed by detection with ECL 
(Amersham Corp., Arlington Heights, IL) to visualize all/3PP species. As 
a control, the immunoblotting step was also carried out with CHO cells sta- 
bly transfected with/3PP695. 
Results 
Cell Surface [3PP  Localization during  Maturation of 
Cultured Hippocampal Neurons 
Shortly  after plating,  hippocampal  neurons  extended  a  la- 
mellipodial  veil  consisting  of  multiple  short  processes 
around  the cell body  (stage  1)  (9).  At this  stage,  immuno- 
Figure  L  Cell surface expres- 
sion of/~PP  in cultured hip- 
pocampal neurons  of varying 
ages.  At stage  1 shortly after 
plating (a),/3PP was seen on 
the surface of perikaryon and 
lamellipodial veil using 5A3/ 
1G'/antfl:mdies.  Paired double- 
labeling images using tubulin 
antibody  (b,  d, f,  and h) and 
5A3/1G'/~PP antibodies (c, e, 
g, and i) were used to demon- 
strate the cellular localization 
of BPP from immature to ma- 
ture  neurons  in  culture.  At 
stage  3  (c),  a  fine  granular 
staining  on  the  surface  of 
soma,  minor neurites,  proxi- 
mal  portion  of an  axon  (ar- 
row), and a  growth cone (ar- 
rowhead) was seen. A neuron 
cultured for 14 d (e) showed a 
characteristic  discontinuous 
and patchy distribution of BPP 
on  the  surface  of  neurites. 
Higher magnification of stage 
5  neurons  seen  in  e  is  illus- 
trated  in g.  In this view, one 
growth  cone  was  immunore- 
active to BPP monoclonal an- 
tibodies (arrowhead) but two 
other growth cones were neg- 
ative  (arrows).  The  patchy 
staining  pattern  of  BPP  on 
neurites  remained  after 28  d 
of culture (i).  Perikaryal BPP 
is illustrated at higher magni- 
fication inj. However, this mi- 
crograph is not truly representative because much of the surface of the cell body as well as the neurites were not within the focal plain 
of the photograph.  Bars:  (a and g)  10/~m;  (c,  e, i, and j) 20 ttm. 
Yamazaki et al. Neuronal Trafficking of~PP  433 Figure 2. Polarized distribution  of cell surface/~PP  in mature neurons. Hippocampal  neurons cultured for 10-14 d (stage 5) were double 
labeled with 5A3/IG7/3PP (F1TC) and MAP2 (rhodamine).  The two photomicrographs  in a and b are representative of the immunofluores- 
cence images obtained from double-labeling  experiments captured in simultaneous  exposure to both fluorophores. Surface/3PP consistently 
showed a characteristic granular discontinuous  staining  pattern (green) on fine nontapering  axons and appeared to be excluded from MAP2 
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extracellular region of flPP strongly labeled the perikaryon 
and the short lamellipodia (Fig.  1 a). Within the first 24 h 
after plating,  neurons  elongate  a  number  of neurites,  of 
which the longest one becomes the axon and the remaining 
processes differentiate into dendrites (stage 3). At this stage, 
both kinds of neurites and cell body demonstrated abundant 
surface flPP immunoreactivity (Fig.  1 c). Of note, the fine 
punctate immunostaining pattern was never present along 
the entire length of  the neurite. Minor neurites were less con- 
sistently labeled. This distribution of cell surface flPP shares 
some  similarities  with  the  pattern  of  intracellular  flPP 
reported previously (12). However, growth cones in contrast 
were  only  occasionally positively  stained  (Fig.  1  c).  At 
14-28 d after plating, neurites in the mature stage (stage 5) 
demonstrated a characteristic discontinuous and patchy pat- 
tern of fine granularity on the cell surface (Fig.  1, e and h). 
As before, neuronal tips remained inconsistently labeled for 
surface flPP (Fig.  1 g). At all stages,/$PP on the surface of 
the perikaryon showed a  fine punctate pattern (Fig.  1 j). 
Identical results described above were obtained with poly- 
clonal (207) and monoclonal (1G7/5A3) antibodies, both of 
which recognize the extracellular domain of flPP. 
Double-labeling  experiments  with  the  somatodendritic 
marker  protein,  MAP2  (microtuble-associated protein 2) 
(1), and the axonal marker protein, growth-associated pro- 
tein 43 (GAP-43) (15), were carded out to identify the neu- 
ritic processes in mature neurons. In these stage 5 cells, flPP 
was generally confined to thin processes that were MAP2 
negative (Fig.  2,  a  and b).  In contrast, the processes im- 
munostained by flPP antibodies were consistently GAP-43 
positive (Fig. 2, c and d). While we could not exclude any 
dendritic localization of flPP,  the pattern of flPP immuno- 
reactivity was distinctly different from proteins that are dis- 
tributed in both axons and dendrites  such as tubulin  (not 
shown)  or  NCAM  (Fig.  2  e).  From  the  double-labeling 
studies, occasional areas  of MAP2 positive dendrites that 
showed apparent flPP immunoreactivity appeared to repre- 
sent immunopositive axons overlapping with those dendritic 
segments. The staining patterns of  flPP, GAP-43, and NCAM 
with respect to MAP2 were absolutely consistent and could 
be reliably distinguished from each other. This was deter- 
mined in a blinded study of photomicrographs taken from 
25 random fields from each set of double-labeled cultures. 
Although qualitatively much  less  intense than  the axonal 
staining,  cell surface flPP was consistently present on the 
perikarya in  mature neurons.  In  sum,  these findings  sug- 
gested that cell surface flPP, like intracellular flPP (12), was 
predominantly localized to axons. 
Cell Surface flPP Molecules Are Full-Length 
To determine whether cell surface flPP immunoreactivity 
represented  full-length  molecules,  neurons  were  double 
Figure 3. Cell surface flPP represents full-length molecules. Neu- 
rites of mature neurons were double labeled with flPP antibodies 
raised against mid-region (SA3/1G7) (a) and the ectodomain region 
between the o~-secretase cleavage site and the cell surface (1963) 
(b). Although the signal intensity differed, the staining pattern of 
the two antibodies was identical. See text for explanation. (c) Hip- 
pocampal neurons were biotinylated at 4°C followed by immuno- 
precipitation with COOH-terminal flPP antibody. Biotinylated sur- 
face flPP species (Surface) migrating at ,o100-110 kD consistent 
with full-length flPP695 isoform can be seen (left lane). This first 
image was obtained by ~25I secondary antibody to antibiotin pri- 
mary antibody. When the same nitrocellulose blot was reincubated 
with COOH-terminal flPP antibody and developed by chemilumi- 
nescence, a lower migrating band (arrowhead) was observed (mid- 
dle lane, Total). This higher intensity nonbiotinylated flPP band is 
consistent with immature BPP species. The flPP species from hip- 
pocampal neurons comigrated with flPP precipitated from CHO 
cells  stably transfected with /~PP695 analyzed in parallel  (right 
lane, I~PP695). Bar in b, 10/~m. 
labeled  with  flPP  monoclonal  antibodies  and  antibodies 
directed against either the ectodomain region of flPP be- 
tween the ot-secretase cleavage site and the cell surface (anti- 
bodies 1963 and aB1) or the carboxy terminus (antibody C7). 
positive dendrites (red). In cultured neurons, axons are frequently associated with dendrites but the two different processes can generally 
be identified. Occasionally, flPP-stained axons would cross over dendrites; at these short segments (arrows), dendrites would appear to 
be positively stained for flPP (in yellow) as a result of the overlap of the two fluorophores. The impression that flPP was generally confined 
to axons was confirmed by double labeling with flPP (c) and GAP-43 (d). Aside from the characteristic patchy distribution of/3PP, the 
two markers otherwise showed virtual overlap in staining. In contrast, the patterns obtained from flPP and GAP-43 immunostaining are 
quite distinct from proteins distributed in both axons and dendrites, as demonstrated by double labeling for NCAM (e) and MAP2 (f). 
Bar,  20 #m. 
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a-secretase cleaved #PPs does not contain this region (10, 41) 
and  thus  would  exclude  the  possibility that  the  staining 
reflected secreted #PPs attached to the cell surface. In ma- 
ture neurons, there was a close correlation between the im- 
munoreactivity obtained by 5A3/1G7 (Fig.  3 a)  and  1963 
(residues 692-708 of/3PP770) (Fig. 3 b) or t~/31. In contrast, 
COOH-terminal/$PP antisera (C7 and 13G8) showed three 
different patterns by indirect immunofluorescence. The first 
pattern in these permeabilized cells consisted of punctate 
granular staining. The second pattern consisted of diffusely 
labeled neurites. These constituted the most common stain- 
ing patterns, as was shown previously (12). Finally, the third 
pattern was infrequently seen and consisted of discontinuous 
patchy labeling reminiscent of the cell surface pattern de- 
scribed above and overlapped with cell surface/3PP visual- 
ized by 5A3/1G7/3PP monoclonal antibodies. Immunostain- 
ing of total/~PP by 5A3/1G7 (Fig. 4,  a  and b) and 207 in 
permeabilized hippocampal neurons showed essentially the 
same pattern as that seen with COOH-terminal antibodies 
(C7 and 13G8). It is noteworthy that after permeabilization, 
~PP  immunoreactivity could be  seen  in  MAP2  positive 
processes with all the/~PP antibodies (Fig. 4). However, in 
mature neurons, the intensity in MAP2 positive dendrites 
was substantially less than that seen in axons and did not have 
the distinctive granularity (Fig. 4, b and c). As expected, im- 
munoreaction of C'/and 1963 antibodies were abolished by 
preabsorption with their corresponding peptides. 
For additional confirmation that/~PP present on the cell 
surface  consisted  of  full-length molecules,  hippocampal 
neurons were surface biotinylated at 4°C followed immedi- 
ately by immungprecipitation with COOH-terminal specific 
antibody. With this approach, full-length biotinylated/3PP 
was recovered from the labeled cell lysates (Fig. 3 c). In ad- 
dition, when the nitrocellulose blot was then immunoblotted 
with the same antibody, a  lower molecular weight nonbi- 
otinylated/~PP species of greater abundance, consistent with 
immature ~PP,  was seen (Fig. 3 c). This latter experiment 
suggested that only cell surface molecules were biotinylated 
and that the more abundant immature species present in- 
traceUularly were not labeled. Taken together, these obser- 
vations from surface/3PP immunostaining and biotinylation 
suggested that cell surface/$PP represents full-length mole- 
cules, rather than secreted molecules that may have adhered 
to the cell surface. 
Internalization of Cell Surface {3PP 
We have previously shown in/3PP-transfected CHO cells that 
cell surface/3PP is rapidly internalized via coated pits and 
subsequently recycled or targeted  to late endosomes and 
lysosomes (Yamazaki,  T., E. H. Koo, E. T. Hedley-Whyte, 
and D. J. Sekoe.  1993. Soc. Neurosci. Abstr. 19:396. To de- 
termine if~PP is similarly internalized from the cell surface 
of primary hippocampal neurons, ceils were incubated with 
~PP monoclonal antibodies 5A3/1G7 for 30 min at 37°C. The 
cells were then fixed, permeabilized, and incubated with sec- 
ondary antibodies. In premature (stage 3) neurons, internal- 
ized/~PP was detected in small granular structures located 
both in axons and in minor neurites and soma (Fig. 5, b and 
d),  indicating the internalization and transport of surface 
/3PP to these sites. When the cells were incubated with both 
/3PP antibodies and fluid phase markers,/3PP was found to 
be colocalized with these markers within the same compart- 
ments (Fig. 5, b-e). As expected, the signal of  the fluid phase 
markers was considerably more intense and more abundant 
than that of internalized/3PP. To exclude the possibility that 
#PP  antibodies  were  internalized  via  nonspecific  (fluid 
phase) endocytosis, the cultures were first incubated with 
whole IgG or Fab fragments of 5A3/1G7/~PP  antibodies at 
4°C before internalization was carried out at 37°C.  Regard- 
less of the conditions of antibody incubation, the staining 
patterns were identical (Fig. 5, fand h), although the signal 
intensity from Fab fragments was weaker than from whole 
IgG. In stage 5 neurons, when axon and dendritic polarity 
is established, internalized/$PP was observed only in axons, 
i.e., MAP2-negative processes (Fig. 5, h and i), suggesting 
that #PP was predominantly internalized from axonal but not 
dendritic sites.  This is consistent with the observation that 
cell surface/3PP was principally located on axons, rather 
than dendrites. When the cells were incubated with the sec- 
ondary antibody without permeabilization or with nonim- 
mune mouse IgG at a concentration identical to 5A3/1GT, no 
staining was observed. In a few experiments, internalization 
of/$PP monoclonal antibodies was carried out during and af- 
ter membrane depolarization to accelerate synaptic vesicle 
recycling (32). However, the results did not change qualita- 
tively after depolarization (data not shown).  In sunmmry, 
these findings indicated that/~PP was rapidly internalized 
from the surface of axons into intracellular compartments 
which also contained fluid phase endocytic markers. 
Retrograde and Transcytotic Transport 
of CeU Surface f3PP 
The above findings demonstrated that in mature hippocam- 
pal neurons, full-length ~PP is primarily present on the sur- 
face of axons and perikarya. The presence of full-length ~PP 
Figure 4.  Intracellular local- 
ization  of  full-length /~PP. 
Both in premature (a) and ma- 
ture  (b)  neurons, intracellu- 
lar 13PP, as detected by 5A3/ 
1G7  antibodies, was  located 
throughout  the cell bodies and 
neurites. Unlike cell surface 
/~PP, MAP2 positive  dendrites 
(c) were slightly immunoreac- 
rive for intracellular/~PP (b). 
Bars: (a) 20 #m; (c) 10 #m. 
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pal neurons.  Living cells  were incubated with 5A3/1G7/~PP anti- 
bodies and dextran-Texas red for 30 rain. In a stage 3 neuron, phase 
contrast photomicrograph (a) shows one long axon (arrows) and 
minor neurites  (arrowheads). The  internalized/3PP  (b) was de- 
tected in immunostained vesicles within an axon (/arge arrows) and 
in the proximal portion of a minor neurite (small arrow). Another 
example of  a premature neuron (d) showed internalized  #PP within 
an axon (arrows) and perikaryon (arrowheads). Some of these la- 
beled vesicles  were colocalized with dextran-Texas  red (c and e). 
Fab fragments of  BPP antibodies labeled at 4°C showed similar pat- 
tern after internalization  (/and h). In a premature neuron (jr) inter- 
nalized/~PP  were located both in an axon (/arge arrows) and minor 
neurites  (small arrows). Panel  g  shows the same neuron from f 
stained with tubulin.  In a mature neuron cultured for 7 d (h), inter- 
nalized BPP (arrows)  were localized only in MAP2 negative neurite 
(i), suggesting an axonal localization.  Panels a, b, and c; d and e; 
fand g; h and i are paired images from double-labeled  cells. Bars, 
10 t*m. 
on the surface of  axons is consistent with the finding that/~PP 
is anterogradely transported in axons and subsequently  in- 
tegrated  into  the  axolemma  (27,  30,  35,  42).  As  demon- 
strated  above,  /~PP  appeared  to  be  internalized  from  the 
axonal or presynaptic terminal membranes. To directly dem- 
Figure 6.  Retrograde transport  of/~PP internalized  from distal 
axons.  In the central chamber of the compartment culture system, 
sympathetic neurons were aggregated in clusters as seen in a bright- 
field phase contrast photomicrograph (a). Only one neuron within 
the  same cluster  (arrow in a)  showed  punctate  staining  in the 
perikaryon (b)  after addition of 5A3/1G7 /~PP antibodies  to the 
lateral chamber.  Occasional proximal  axons also demonstrated in- 
tracellular  vesicular  irnmunostaining  (c).  See  Materials  and 
Methods and text  for detail.  Bars: (a) 50/,m; (b and c) 25/,m. 
onstrate the internalization  of/~PP from distal axonal sites 
and  retrograde  transport  back to perikarya,  neurons  were 
grown in a  compartment culture system (4) that effectively 
isolated the perikarya from distal axons and terminals.  Dis- 
sociated rat sympathetic neurons were cultured in the middle 
chamber of this three compartment system such that neurites 
gradually extended underneath the dividing wall into the two 
lateral chambers, usually 4-6 d after plating. The uniqueness 
of this  system is that aside from the neuritic growth, there 
is no mixing of the media within the different compartments. 
Sympathetic neurons are known to extend only axons when 
cultured alone without glia in serum-free medium,  thereby 
excluding dendrites  from the culture system (20).  In these 
experiments,/~PP monoclonal antibodies were added only to 
the  lateral  chambers,  into  which  axons  had  penetrated. 
6-8 d after plating, the distal axons and terminals were then 
incubated with 5A3/1G7/3PP antibodies at 37°C for 3 h  fol- 
lowed  by  fixation,  permeabilization,  and  incubation  with 
secondary  antibody.  Sympathetic  neurons  were  usually 
found to be distributed in small aggregates (Fig. 6 a). In the 
central compartment,  one or two cells  in such a  cluster of 
neurons demonstrated  abundant  vesicular/3PP  staining  in 
Yamazaki et al. Neuronal Tra~cking of [3PP  437 Figure 7. Transferrin receptors are excluded from axons. Polarity 
of sympathetic neurons was demonstrated by the presence of trans- 
ferrin receptors  only on the perikaryon (arrowhead) but not in 
axons (b). Phase contrast photomicrograph (a) of the correspond- 
ing cell seen in b shows the perikaryon of a neuron (arrowhead) 
within a network of axons (arrows). Bar, 50 #m. 
To examine the transcytosis of  cell surface BPP from axons 
to perikarya, the same compartment culture experiment per- 
formed above was repeated. However, after the incubation of 
flPP monoclonal antibodies in the lateral chamber, second- 
ary antibodies were added in the central chamber without 
permeabilization. With this approach, peripheral punctate 
staining was observed on the perikaryal surface of neurons 
in the central compartment (Fig. 8 a), indicating transcytosis 
of BPP from axonal to somatic sites. Compared to intracellu- 
lar flPP in the cell body derived by retrograde transport (Fig. 
6 c), the intensity was significantly less and the staining pat- 
tern was  more fine and  less  vesicular.  As before, only a 
minority of neurons in the central chamber was positively 
stained. Interestingly a few proximal axons within the cen- 
tral compaim~ent also showed small punctate surface stain- 
ing, indicating the recycling of internalized/3PP to the axonal 
surface. 
To determine whether this transport pathway is dependent 
their cytoplasm, similar to that seen in hippocampal neurons 
above (Fig.  6  b),  suggesting that only these neurons have 
internalized the BPP antibodies from their distal axons. In 
addition,  small  vesicles  in  proximal axons in  the central 
chamber were occasionally immunoreactive (Fig. 6 c). On 
average, ,020 % of  neurons were immunopositive, suggesting 
that only a  fraction of neurons have successfully extended 
their axons into one of the two lateral chambers. In contrast, 
when the central, rather than lateral, compartment contain- 
ing the cell bodies was incubated with flPP antibodies, all the 
neuronal perikarya and processes were immunostained for 
intracellular/3PP  (data  not  shown).  This result provided 
confirmation that ~PP antibodies added in the lateral cham- 
bers had not leaked into the central chamber; otherwise, all 
cells, not just a few cells within a cluster, would have been 
positive.  As  additional  negative  controls,  cells  incubated 
with either nonimmune mouse IgG instead of  ~PP antibodies 
or without primary antibody showed no reaction. In sum, 
these observations provided convincing evidence that flPP 
molecules were internalized from the surface of  distal axonal 
sites and carried by retrograde axonal transport back to the 
cell body. 
Because flPP is present not only on the axonal but also the 
perikaryal surface, we speculated that flPP may also be trans- 
ported transcytotically from the axonal to the perikaryal sur- 
face  compartment.  To  demonstrate  the  flPP  transcytotic 
pathway, we first showed that sympathetic neurons consisted 
of  two different compartments, akin to cultured hippocampal 
neurons and epithelial cells. Accordingly, when sympathetic 
neurons were incubated with transferrin conjugated to Texas 
red, uptake was observed only in perikarya (Fig. 7 b) but not 
axons. Therefore, in the absence of dendrites, cultured sym- 
pathetic neurons nevertheless consisted of distinct axonal 
and somatic compartments (3). 
Figure & Transcytosis of cell surface flPP from axons to perikarya 
in compartment culture system. In the central chamber of  the com- 
partment culture system,/3PP antibodies added to the lateral cham- 
ber can be seen on the surface of neuronal cell body (a) or proximal 
axon  (b).  Internalized  13PP was  absent  from  the  surface  of 
perikaryal membrane (c) but present on proximal axons (d) after 
BFA treatment. However,  addition of BFA did not impair transport 
of t3PP to perikarya (e) or in axons (f) as detected by secondary 
antibody after permeabilization. Bars, 25 #m. 
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nocodazole to depolymerize microtubules (48).  With this 
treatment, no reaction was seen within either the perikarya 
or proximal axons (data not shown), although cell surface 
/3PP and internalized/3PP remained at distal axons in the 
lateral compartment.  In addition, cells were treated with 
brefeldin A (BFA), an agent which has been shown to inhibit 
l~gure 9. Cell surface/SPP in hiPtx~ampal neurons after kinesin 
antisense oligonucleotide. HiPlX~carnpal neurons cultured for 5 d 
were incubated for 36 h with kinesin heavy chain antisense (a-d) 
or sense (e-h) oligonucleotides. Cells were double labeled with 
kinesin antibody (a and e) or 5A3/1G7 BPP antibodies (c and g) and 
tubulin antibody (b, d, f, and h). With antisense oligonucleotide 
treatment, BPP was absent from the surface of neurites and cell 
body (c). Immunostaining of kinesin in the cell body was dramati- 
cally diminished with antisense oligonueleotide  (a). With sense oli- 
gonucleotide  treatment, cell surface/~PP showed  the typical patchy 
pattern  on  neurites (g)  and  kinesin  was  normally  distributed 
throughout the cell (e). In g, the plain of focus was on the neurites, 
therefore, perikaryal staining cannot be appreciated in this pho- 
tomicrograph. Bars, 20/~m. 
transcytosis in MDCK cells (22).  After BFA pretreatment, 
no signal could be detected on the perikaryal surface (Fig. 
8 c), although occasional proximal axons showed punctate 
immunoreactivity (Fig. 8 d). Moreover, if the neurons were 
permeabilized before the addition of secondary antibody, 
vesicular BPP staining was present within the perikarya (Fig. 
8 e). This suggested that BFA did not alter internalization, 
recycling, or retrograde transport of/SPP but was selective 
for the transcytotic pathway (22). 
To extend the study to neurons of the central nervous sys- 
tem, an alternative experimental approach was used because 
hippocampal neurons could not be successfully grown in the 
same compartment culture  system. In these experiments, 
kinesin heavy chain synthesis was inhibited by the addition 
of antisense oligonucleotide to the medium of hippocampal 
neurons (12). The rationale is that the anterograde axonal 
transport of/~PP should  be mediated by a kinesin based rapid 
organdie transport system. Thus, the impairment of kinesin 
should retard not only the transport of/3PP to distal axonal 
sites as shown before (12) but also inhibit delivery of/3PP 
to the retrograde axonal and transcytotic pathways, if/SPP in 
the latter trafficking steps originated from the anterograde 
axonal pool.  The absence of/3PP on the axonal and peri- 
karyal surfaces would be consistent with this scenario. After 
treatment with antisense oligonucleotide, neurons showed 
markedly reduced intraceUular immunostaining for kinesin 
(Fig. 9 a), and an absence of call surface/3PP immunoreac- 
tivity on both the axon and cell body (Fig. 9 c). Similarly, 
synaptophysin immunostaining in axons was abolished (Fig. 
10  c).  Importantly, immunoreactivity of treated cells  for 
transferrin receptor (Fig. 10 a) or transferrin uptake (Fig. 10 
b) was not altered, demonstrating that the exocytic pathway 
to the surface of the perikaryon was not impaired. Control 
cultures treated with sense oligonucleotide showed essen- 
tiaUy no change from untreated cells (Fig. 9, e and g and Fig. 
10 e). Finally, to determine whether this inhibition of/3PP 
transcytosis is reversible, cells treated with antisense oligo- 
nucleotide were cultured for two additional days in the ab- 
sence  of oligonucleotide.  After this  washout period,  the 
characteristic patchy pattern of cell surface #PP was ob- 
served (Fig.  10 f). Taken together, these results suggested 
that  retrograde  axonal and transcytotic transport  of/3PP 
from distal axonal sites may also occur in neurons of  the cen- 
tral nervous system. 
Discussion 
In this report,  we described a detailed localization of cell 
surface/3PP and its subsequent trafficking in primary cul- 
tured neurons. The study was undertaken for several rea- 
sons: (a) neurons have long been hypothesized to be a prin- 
cipal source of A/3 in brain, (b) the internalization pathway 
of/3PP in neurons, which may be an important contributor 
to AB formation (28), has not been examined, and (c) we re- 
cently described the polarized sorting and secretion of BPP 
in MDCK cells (18). Therefore, trafficking of/3PP must be 
understood within the context of previous studies on the lo- 
calization of  BPP in neurons and the cellular trafficking  path- 
way of/3PP in MDCK cells. We report here that in mature 
primary hippocampal neurons, full-length BPP was located 
principally on the membrane surface of  axons and perikarya. 
From distal axons or terminals, cell surface/~PP, as deter- 
Yamazaki et al. Neuronal Trafficking of/3PP  439 Figure 10. Kinesin antisense  oligonucleotide  did not inhibit the exo- 
cytic transport of transferrin receptor (a) or transferrin uptake (b). 
Antisense oligonucleotide  inhibited the axonal localization of syn- 
aptophysin (c), although with addition of sense oligonucleotide, 
synaptophysin  could be seen in axons (e). Panel d shows the same 
neuron seen in c double labeled with tubulin. After washout  of  kine- 
sin antisense oligonucleotide  for 2 d, normal cell surface BPP was 
seen on the perikaryon and neurites (f). Bars, 10 #m. 
mined by the binding of monoclonal antibodies to/3PP, was 
internalized and transported retrogradely back to the peri- 
karyon in organelles which in part colocalized with fluid 
phase markers. Internalization and retrograde transport of 
BPP were shown in both hippocampal and peripheral sym- 
pathetic neurons, the latter using an established compart- 
ment culture system. Unexpectedly, in addition to targeting 
of internalized molecules to the cell body, presumably for 
degradation,/3PP was also sorted transcytotically from the 
axonal to the somatic surface compartments. 
Initial published  results  of BPP  trafficking in  neurons 
demonstrated the anterograde axonal transport of full-length 
BPP (27).  Subsequent studies reported that/3PP may be in- 
serted  into the axolemma (35)  or transported distally to 
presynaptic nerve terminals (30, 37).  Our studies now add 
to this trafficking  pathway by showing that at distal sites, BPP 
is  actively internalized from the axolemmal surface  and 
retrogradely transported back to the cell body as full-length 
molecules.  At growth cones,  ~PP  was  inconsistently de- 
tected on the membrane surface, a result that is distinct from 
the invariant localization of intracellular BPP  at the same 
sites (12). Therefore, we speculate that BPP is actively en- 
docytosed and possibly recycled at growth cones. In addi- 
tion, along the surface of the axon, recycling of BPP appears 
to take place. Finally, the compartment culture system used 
in this study is only able to isolate cell bodies from distal 
axons and terminals, and cannot differentiate between the 
latter two sites. Consequently, whether the turnover rate of 
/3PP along the surface of the axolemma is different than at 
growth cones cannot be determined. 
Previous reports describing the neuronal localization of 
/3PP focused on the intraceLlular distribution of the molecule 
using antibodies specifically recognizing the carboxy termi- 
nus of/3PP (5, 12). Therefore, those studies could not deter- 
mine whether the distribution of/SPP represented predomi- 
nantly full-length or NH2 terminally truncated species.  We 
found that in mature neurons, the predominant axonal local- 
ization of/3PP is preserved for both surface and intracellular 
populations of/SPP molecules. Along the axonal surface, 
BPP is distributed in a characteristically discontinuous pat- 
tern. At these patchy surface sites and at growth cones,/SPP 
is  closely associated with the /3-integrins  (YamaT~ki, T., 
D. J. Selkoe, and E. H. Koo, manuscript in preparation), a 
feature that may be related to the putative role of BPP in ad- 
hesion (29, 36).  However, the distinctive discontinuous pat- 
tern of cell surface/3PP immunostaining along the axonal 
shaft was lost when the cells were first permeabilized with 
detergent. We hypothesize that the intracellular pool of/SPP 
is either considerably larger than the surface pool of mole- 
cules or the latter is rapidly turned over so that only a few 
molecules are present on the surface at steady state. Evi- 
dence for the former is  seen in the appearance of minor 
amounts of intracellular, but not surface, BPP in dendrites. 
Furthermore, we did not observe a correlation between cell 
surface  BPP  and  structures  immunoreactive for  clathrin 
(data not shown), as was reported previously (12). This sug- 
gested that the colocalization of COOH-terminal 8PP anti- 
bodies with clathrin structures represented primarily trun- 
cated BPP species. This interpretation is consistent with both 
the detection of the 10-kD  COOH-terminal membrane re- 
tained BPP  fragments in clathrin-coated vesicles isolated 
from PC12 cells (31) and the redistribution of BPP immuno- 
reactive  organdies  after  acidification of the  culture  me- 
dium (12). 
Upon maturation, neurons exhibit striking polarity man- 
ifested by the long slender axon and the extensive dendritic 
arborizations.  To  maintain  these  functional  differences, 
axons and dendrites are differentially separated into distinct 
plasma membrane domains (25, 34). Based on initial studies 
of the surface distribution of viral glycoproteins in neurons 
and epithelial cells, it was suggested that axonal/apical and 
somatodendritic/basolateral membranes may represent anal- 
ogous domains to the extent that polarized targeting in neu- 
rons and epithelial cells may share similar signals or path- 
ways (7, 8, 23).  We have recently examined the sorting of 
BPP in MDCK cells and found that both the distribution of 
cell surface ~PP and the secretion of BPP proteolytic prod- 
ucts favored the basolateral compartment (18). This finding 
might be expected, in view of the putative role of/3PP in 
adhesion and by its association with integrins and laminin 
(26). By analogy, one would therefore predict a somatoden- 
dritic sorting pattern of BPP in cultured hippocampal neu- 
rons.  However,  our results demonstrated that cell surface 
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dendrites, an observation that is consistent with the previous 
demonstration of intracellular  ~/PP in axons and at growth 
cones (12, 37). Therefore, BPP joins a list of molecules and 
other cellular properties that do not fit this apical/axonal as- 
sociation, and the extent to which the polarity of neurons re- 
sembles epithelial cells remains unclear. 
The transport  of molecules in epithelial  cells from one 
plasma  membrane  (apical  or  basolateral)  to  the  other  is 
known as transcytosis. This is an important cellular pathway 
because in epithelial cells, the two compartments are effec- 
tively separated  from  each  other  by tight junctions  (34). 
Based  on  the  transport  of exogenous  molecules  such  as 
viruses and toxins, both transcytotic and transsynaptic path- 
ways have been described in neurons. Recently, using a viral 
expression system, the polymeric immunoglobulin receptor 
was shown to redistribute  from somatodendritic  to axonal 
domains with the addition of dimeric IgA, a result that implies 
transcytosis of this receptor molecule (23). Our result show- 
ing the transcytotic transport of BPP from axons  to peri- 
karyal surface is, to our knowledge, the first demonstration 
of the use of a constitutive transcytotic pathway by an endog- 
enous  neuronal  protein,  This  pathway  was  demonstrated 
directly in sympathetic neurons by the transport of monoclo- 
nal BPP antibodies from distal axonal sites to the perikaryal 
surface in a  compartment  culture system.  In hippocampal 
neurons,  addition  of antisense  oligonucleotides to kinesin 
heavy chain resulted in virtually no staining of cell surface 
BPP in either axons or perikarya. The absence of BPP on the 
axolemmal surface is consistent with the known anterograde 
transport of BPP (12, 27). More importantly, the concomi- 
tant loss of BPP on the perikaryal surface suggests that the 
molecules targeted to the somatodendritic compartment may 
be derived principally from the transcytotic route.  This in- 
terpretation  assumes  that  transeytotic  transport  from  the 
soma is not mediated by kinesin because exocytic sorting of 
transferrin receptor was not affected. As such, the evidence 
that a similar BPP transcytotic pathway exists in hippocam- 
pal neurons is indirect. In addition, we found that this trans- 
cytotic pathway is sensitive to BFA treatment,  an agent that 
has been shown to selectively block transcytosis in MDCK 
cells  without  impairing  internalization  or  recycling  (22). 
Thus, the inhibition of BPP transcytosis by BFA is particu- 
larly interesting and suggests that a sorting step required for 
transcytosis is functionally similar between MDCK cells and 
neurons. 
Our study did not identify the organelle  that transports 
BPP retrogradely  to the cell body. It has previously been 
shown that axonally transported organelles containing fluid 
phase markers consisted mostly of multivesicular body-like 
structures (32).  Thus,  if flPP were carried in these organ- 
elles,  as suggested by the colocalization of ~/PP and fluid 
phase markers,  then it would imply that in the perikaryon, 
these  vesicles  can  still  be  sorted  transcytoticaUy  to  the 
perikaryal surface and not necessarily committed to the late 
endosome/lysosomal system for degradation.  It is not clear 
from our studies whether internalized  and/or retrogradely 
transported/~PP molecules can be redirected anterogradely 
into the axon. 
Finally, the significance of this trafficking pathway of BPP 
to either constitutive AB production or amyloid deposition 
in brains of Alzheimer's disease subjects is unclear at this 
time.  Recent studies have implicated the internalization  of 
cell surface BPP in cultured cells as an important contributor 
to A/5 subsequently released into the medium (27). Whether 
A~ generation in neurons involves the endocytic pathway is 
unknown. However, it should be noted that the abnormal dis- 
tribution  of lysosomes in  neurons  is  a  consistent  finding 
in  Alzheimer's  disease,  especially  within  dystrophic neu- 
rites surrounding deposits of B-amyloid (6, 44).  Therefore, 
whether this abnormal displacement of the lysosomal system 
alters  the  normal  ~PP trafficking  pathway defined  in  this 
study, thereby contributing  to the pathogenesis of AD,  re- 
mains an interesting  speculation. 
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